First Source Inc., provider of digital X-ray technology upgrades and services for the medical imaging market, announced the launch of its new business division, Visaris Americas. The new division will incorporate an innovative product portfolio of digital X-ray imaging technology to meet the growing needs of its business channels.

A new phase of the Breast Cancer and the Environment Research Program (BCERP), focused on prevention, is being launched at the National Institutes of Health. Grant-funded researchers will now work across scientific disciplines, involve new racially and ethnically diverse communities, and expand the study of risk factors that precede breast cancer, such as breast density.


Twenty years ago whole body scanners were a fad. It wasn’t called that. But it had the earmarks. Wild enthusiasm. Widespread adoption.

Now their makers are trying to return to those glory days. 

These scanners became popular in the mid-1990s by providing dual-energy X-ray absorptiometry (DXA) to assess osteoporosis. GE Lunar and Hologic now are promoting DXA scanners for a different purpose — to determine body composition through scans that detail the relationship between fat, bone and lean tissue.


In the early days of radiology, data entry errors by radiology technologists were common. Their attention, after all, was on the patient and the modality, not the clerical task of typing. To address this, DICOM Modality Worklist (aka DMWL) was adopted.

DMWL took the textual patient and imaging procedure order information entered into the HIS or RIS and made it available within the DICOM image objects, without retyping. The productivity and information quality gains were significant.


Dell Inc. and EMC Corporation today announced they have signed a definitive agreement under which Dell, together with its owners, Michael S. Dell, founder, chairman and chief executive officer of Dell, MSD Partners and Silver Lake, the global leader in technology investing, will acquire EMC Corporation, while maintaining VMware as a publicly-traded company. 


The outlook of breast cancer is changing, and death rates have been decreasing since 1989, thanks in part to treatment advances, earlier detection through screening and increased awareness. 



The digital breast tomosynthesis (DBT) market has evolved rapidly within the past year, with new vendors entering the market and recent clinical data continuing to support its use. In addition, the Centers for Medicare and Medicaid Services (CMS) created dedicated reimbursement codes for DBT procedures earlier this year.



The U.S. House of Representatives on July 10 passed its version of the 21st Century Cures Act (H.R. 6), designed to improve the U.S. healthcare innovation infrastructure. 



As healthcare converts to an entirely electronic health record (EHR)-based system, it opens up new opportunities to monitor trends in population health and even identify specific patients for follow-up in targeted populations. 


Subscribe Now